Literature DB >> 20013311

Wireless capsule endoscopy in enteropathy induced by nonsteroidal anti-inflammatory drugs in pigs.

Ilja Tachecí1, Jaroslav Kvetina, Jan Bures, Jan Osterreicher, Martin Kunes, Jaroslav Pejchal, Stanislav Rejchrt, Stanislav Spelda, Marcela Kopácová.   

Abstract

AIM: The aim of this study is to evaluate the diagnostic yield of capsule endoscopy in nonsteroidal anti-inflammatory drug (NSAID)-induced enteropathy in pigs.
MATERIALS AND METHODS: Indomethacin (400 mg/day) was administrated orally for 10 days to eight female pigs weighing 36.3+/-2.4 kg. Afterwards, capsule endoscopy was performed, using the EndoCapsule system (Olympus Optical Co., Tokyo, Japan). The following morning, pharmacological euthanasia and immediate autopsy were performed.
RESULTS: Small bowel injury compatible with NSAID-induced enteropathy was observed in 7/8 animals. The most common lesions were red spots and erosions. Ulcers and small intestinal bleeding were identified sporadically. Sensitivity and specificity of capsule endoscopy were 83.3% and 95.8%, respectively.
CONCLUSION: Our results indicate that wireless capsule endoscopy is a highly accurate noninvasive method for evaluation of experimental NSAID-induced enteropathy.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20013311     DOI: 10.1007/s10620-009-1066-z

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  24 in total

1.  The effect of erythromycin on video capsule endoscopy intestinal-transit time.

Authors:  Grant R Caddy; Lawrence Moran; Andre K H Chong; Ashley M Miller; Andrew C Taylor; Paul V Desmond
Journal:  Gastrointest Endosc       Date:  2006-02       Impact factor: 9.427

2.  Intestinal toxicity of ketoprofen-trometamol vs its enantiomers in rat. Role of oxidative stress.

Authors:  C A de la Lastra; A Nieto; V Motilva; M J Martín; J M Herrerías; F Cabré; D Mauleón
Journal:  Inflamm Res       Date:  2000-11       Impact factor: 4.575

3.  Evaluation of gastrointestinal toxicity of ibuprofen using surrogate markers in rats: effect of formulation and route of administration.

Authors:  T Khazaeinia; F Jamali
Journal:  Clin Exp Rheumatol       Date:  2000 Mar-Apr       Impact factor: 4.473

4.  Visible small-intestinal mucosal injury in chronic NSAID users.

Authors:  David Y Graham; Antone R Opekun; Field F Willingham; Waqar A Qureshi
Journal:  Clin Gastroenterol Hepatol       Date:  2005-01       Impact factor: 11.382

5.  Gastrointestinal mucosal injury following repeated daily oral administration of conventional formulations of indometacin and other non-steroidal anti-inflammatory drugs to pigs: a model for human gastrointestinal disease.

Authors:  K D Rainsford; P I Stetsko; S P Sirko; S Debski
Journal:  J Pharm Pharmacol       Date:  2003-05       Impact factor: 3.765

6.  Intestinal ulcerogenic effect of S(+)-ketoprofen in the rat.

Authors:  F Cabré; F Fernández; M I Zapatero; A Araño; M L García; D Mauleón
Journal:  J Clin Pharmacol       Date:  1998-12       Impact factor: 3.126

Review 7.  Comparison of the gastrointestinal anatomy, physiology, and biochemistry of humans and commonly used laboratory animals.

Authors:  T T Kararli
Journal:  Biopharm Drug Dispos       Date:  1995-07       Impact factor: 1.627

8.  Long-term effects of nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective agents on the small bowel: a cross-sectional capsule enteroscopy study.

Authors:  Laurence Maiden; Bjarni Thjodleifsson; Anna Seigal; Ingvar Iain Bjarnason; David Scott; Sigurbjorn Birgisson; Ingvar Bjarnason
Journal:  Clin Gastroenterol Hepatol       Date:  2007-07-10       Impact factor: 11.382

9.  Less small-bowel injury with lumiracoxib compared with naproxen plus omeprazole.

Authors:  Christopher J Hawkey; Christian Ell; Bernd Simon; Jörg Albert; Martin Keuchel; Mark McAlindon; Paul Fortun; Stefan Schumann; Wolfgang Bolten; Anthony Shonde; Jean-Louis Hugot; Vincent Yu; Udayasankar Arulmani; Gerhard Krammer; Rosemary Rebuli; Ervin Toth
Journal:  Clin Gastroenterol Hepatol       Date:  2008-01-31       Impact factor: 11.382

10.  Wireless video capsule enteroscopy in preclinical studies: methodical design of its applicability in experimental pigs.

Authors:  Marcela Kopácová; Ilja Tachecí; Jaroslav Kvetina; Jan Bures; Martin Kunes; Stanislav Spelda; Vera Tycová; Zbynek Svoboda; Stanislav Rejchrt
Journal:  Dig Dis Sci       Date:  2009-03-18       Impact factor: 3.199

View more
  6 in total

1.  Capsule endoscopy in nonresponsive celiac disease.

Authors:  David S Atlas; Alberto Rubio-Tapia; Carol T Van Dyke; Brian D Lahr; Joseph A Murray
Journal:  Gastrointest Endosc       Date:  2011-08-11       Impact factor: 9.427

2.  Capsule-odometer: a concept to improve accurate lesion localisation.

Authors:  Alexandros Karargyris; Anastasios Koulaouzidis
Journal:  World J Gastroenterol       Date:  2013-09-21       Impact factor: 5.742

3.  Bacteriocinogeny in experimental pigs treated with indomethacin and Escherichia coli Nissle.

Authors:  Jan Bures; David Smajs; Jaroslav Kvetina; Miroslav Förstl; Jan Smarda; Darina Kohoutova; Martin Kunes; Jiri Cyrany; Ilja Tacheci; Stanislav Rejchrt; Jirina Lesna; Viktor Vorisek; Marcela Kopacova
Journal:  World J Gastroenterol       Date:  2011-02-07       Impact factor: 5.742

4.  Preclinical electrogastrography in experimental pigs.

Authors:  Jaroslav Květina; Jithinraj Edakkanambeth Varayil; Shahzad Marghoob Ali; Martin Kuneš; Jan Bureš; Ilja Tachecí; Stanislav Rejchrt; Marcela Kopáčová
Journal:  Interdiscip Toxicol       Date:  2010-06

Review 5.  Role of Sulforaphane in Protection of Gastrointestinal Tract Against H. pylori and NSAID-Induced Oxidative Stress.

Authors:  Akinori Yanaka
Journal:  Curr Pharm Des       Date:  2017       Impact factor: 3.116

Review 6.  Gut Microbiota in NSAID Enteropathy: New Insights From Inside.

Authors:  Xianglu Wang; Qiang Tang; Huiqin Hou; Wanru Zhang; Mengfan Li; Danfeng Chen; Yu Gu; Bangmao Wang; Jingli Hou; Yangping Liu; Hailong Cao
Journal:  Front Cell Infect Microbiol       Date:  2021-07-06       Impact factor: 5.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.